India-US to begin joint Ayurvedic Clinical trials for COVID-19
On July 9, 2020, India and United States began joint Ayurvedic Clinical trials against COVID-19. The joint research is to be supported by the Indo-US Science Technology Forum (IUSSTF).
Highlights
There are three ongoing collaborations between US-based institutions and India Vaccine companies.
Other Projects
Both the countries have been conducting several such projects. This includes the following
- There are more than 200 National Institute of Health funded projects in India. These projects involve more than 20 institutions in the NIH network.
- India and US have been collaborating under Vaccine Action Programme (VAP) that resulted in the development of ROTAVAC Vaccine against the Rota virus. Rota Virus causes diarrhea in children.
- The countries through their collaborative programmes have developed vaccines for Influenza, Tuberculosis, Chikungunya under the Vaccine Action Programme.
Vaccine Action Programme
It is a 33-year collaboration between India and USA. The partners under the programme include National Institutes of Health, USA, Department of Biotechnology (DBT) and Indian Council of Medical Research.
Month: Current Affairs - July, 2020
Category: International / World Current Affairs
Topics: Ayurveda • COVID-19 • COVID-19 Ayurvedic trials • COVID-19 vaccine • India-US • India-USA Relations • IUSSTF • ROTAVAC • Rotavirus vaccine • vaccine action programme
Latest E-Books
Current Affairs Articles Compilation [PDF] - January, 2023 | ₹200.00 | ||
Current Affairs [PDF] - January 16-31, 2023 | ₹100.00 | ||
Current Affairs [PDF] - January 1-15, 2023 | ₹100.00 | ||
View All E-Books: Recent Release |
Comments